Overview

Clinical Trials to Assess the Efficacy and Safety of HLIM

Status:
Unknown status
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of HLIM
Phase:
Phase 3
Details
Lead Sponsor:
SamA Pharmaceutical Co., Ltd